Inventaire - your friends and communities are your best library

Ligands act as pharmacological chaperones and increase the efficiency of delta opioid receptor maturation

Author

Michel Bouvier

Published in: The EMBO Journal

Date of publication: April 1, 2002

Language: English

Main subject: molecular chaperone, opioid, pharmacology

Bibliographic databases:

Cites articles 42

Date

Title

Authors

August 1987

High-efficiency transformation of mammalian cells by plasmid DNA
March 10, 1989

Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: evidence for membrane cycling from Golgi to ER
January 1, 1992

Site-directed mutagenesis of virtually any plasmid by eliminating a unique site
May 1, 1994

Structure and function in rhodopsin. 7. Point mutations associated with autosomal dominant retinitis pigmentosa
May 1, 1995

Opiate receptor changes after chronic exposure to agonists and antagonists,Opiate Receptor Changes after Chronic Exposure to Agonists and Antagonists
June 1, 1996

Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein,Chemical chaperones correct the mutant phenotype of the ΔF508 cystic fibrosis transmembrane conductance regulator protein
August 1, 1996

Involvement of Trp-284, Val-296, and Val-297 of the human delta-opioid receptor in binding of delta-selective ligands
January 1, 1996

Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation.
January 1, 1997

Ligand-induced overexpression of a constitutively active beta2-adrenergic receptor: pharmacological creation of a phenotype in transgenic mice
January 1, 1997

Structural instability of a constitutively active G protein-coupled receptor. Agonist-independent activation due to conformational flexibility

,
August 1, 1997

Up-regulation of the levels of expression and function of a constitutively active mutant of the hamster alpha1B-adrenoceptor by ligands that act as inverse agonists,Up-regulation of the levels of expression and function of a constitutively active mutant of the hamster α1B-adrenoceptor by ligands that act as inverse agonists
May 1, 1997

Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice
January 1, 1997

Correction of defective protein kinesis of human P-glycoprotein mutants by substrates and modulators
September 1, 1998

Effect of vitamin A supplementation on rhodopsin mutants threonine-17 --> methionine and proline-347 --> serine in transgenic mice and in cell cultures,Effect of vitamin A supplementation on rhodopsin mutants threonine-17 → methionine and proline-347 → serine in transgenic mice and in cell cultures
August 1, 1998

Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints,Opioid Receptor Three-Dimensional Structures from Distance Geometry Calculations with Hydrogen Bonding Constraints
May 1, 1998

Defective aquaporin-2 trafficking in nephrogenic diabetes insipidus and correction by chemical chaperones
April 1, 1998

Endocrinopathies in the family of endoplasmic reticulum (ER) storage diseases: disorders of protein trafficking and the role of ER molecular chaperones,Endocrinopathies in the Family of Endoplasmic Reticulum (ER) Storage Diseases: Disorders of Protein Trafficking and the Role of ER Molecular Chaperones*
January 1, 1998

Mutagenesis of the mouse delta opioid receptor converts (-)-buprenorphine from a partial agonist to an antagonist
December 3, 1999

Setting the standards: quality control in the secretory pathway
October 29, 1999

Correction of defective protein trafficking of a mutant HERG potassium channel in human long QT syndrome. Pharmacological and temperature effects
September 1999

The delta-opioid receptor: molecular pharmacology, signal transduction, and the determination of drug efficacy
July 1, 1999

Integration of endoplasmic reticulum signaling in health and disease
November 1, 1999

Characterization of [125I]AR-M100613, a high-affinity radioligand for delta opioid receptors
January 1, 1999

Biosynthesis and degradation of CFTR.
January 1, 1999

Accelerated transport and maturation of lysosomal alpha-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor
April 1, 1999

6-Aminohexanoic acid as a chemical chaperone for apolipoprotein(a)
December 20, 2000

Proper folding and endoplasmic reticulum to golgi transport of tyrosinase are induced by its substrates, DOPA and tyrosine
December 1, 2000

Pharmacological chaperones: a new twist on receptor folding

,
October 27, 2000

Newly synthesized human delta opioid receptors retained in the endoplasmic reticulum are retrotranslocated to the cytosol, deglycosylated, ubiquitinated, and degraded by the proteasome
October 1, 2000

Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function.
August 4, 2000

Crystal structure of rhodopsin: A G protein-coupled receptor

,
May 5, 2000

Export from the endoplasmic reticulum represents the limiting step in the maturation and cell surface expression of the human delta opioid receptor

Article -

Welcome to inventaire

The library of your friends and communities

You are offline